Atlas Trials

Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens

Clinical trial NCT05871489 · UNKNOWN

Trial details

NCT number
NCT05871489
Sponsor
Harvard Medical School (HMS and HSDM)
Status
UNKNOWN
Study type
OBSERVATIONAL
Tuberculosis, Multidrug-ResistantHIV
Start date
2020-09-22
Primary completion
2025-12-30
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.